MARKET

LOBEF

LOBEF

Lobe Sciences
OTCMQB
0.048
NaN%
Closed 09:30 10/02 EDT
OPEN
--
PREV CLOSE
0.043
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.108
52 WEEK LOW
0.022
MARKET CAP
16.08M
P/E (TTM)
-2.5638
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LOBEF last week (0921-0925)?
Weekly Report · 6d ago
Weekly Report: what happened at LOBEF last week (0914-0918)?
Weekly Report · 09/21 10:19
Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
Barchart · 09/14 22:00
Weekly Report: what happened at LOBEF last week (0907-0911)?
Weekly Report · 09/14 10:24
Weekly Report: what happened at LOBEF last week (0831-0904)?
Weekly Report · 09/07 10:17
Lobe Sciences Raises $2.16 Million in Upsized Private Placement to Advance Sickle Cell Drug
TipRanks · 09/01 01:02
Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement
Barchart · 08/31 18:00
Weekly Report: what happened at LOBEF last week (0824-0828)?
Weekly Report · 08/31 10:25
More
About LOBEF
Lobe Sciences, Ltd. is a biopharmaceutical company focused on using lipid technology to develop treatments for orphan and rare diseases. The Company, through its wholly owned subsidiaries, Alera Pharma, Inc. and Altemia, Inc., is advancing the development of a patented drug candidate aimed at treating neurological disorders, with an initial focus on chronic cluster headache (Alera). The Company commercializes Altemia MF, a medical food designed to manage deficiencies commonly found in sickle cell disease. Additionally, through Cynaptec Pharmaceuticals, Inc. (Cynaptec), the Company retains an interest in developing Conjugated Psilocin in neurology and psychiatric indications. Conjugated Psilocin is a patented, oral, stable analog of psilocin, the active metabolite of the prodrug psilocybin, designed to enhance bioavailability and therapeutic efficacy, which has been identified as having therapeutic potential in a variety of neurological conditions.

Webull offers Lobe Sciences Ltd stock information, including OTCMQB: LOBEF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LOBEF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LOBEF stock methods without spending real money on the virtual paper trading platform.